These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications. Nelson TE; Lin M; Zapata-Sudo G; Sudo RT Anesthesiology; 1996 Jun; 84(6):1368-79. PubMed ID: 8669678 [TBL] [Abstract][Full Text] [Related]
25. Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation. Aires CCG; de Souza RRL; Amorim JA; Santos FG; Diniz DA; Carneiro SCAS; Vasconcellos RJH Spec Care Dentist; 2023 Jan; 43(1):99-108. PubMed ID: 35667046 [TBL] [Abstract][Full Text] [Related]
26. Is there a link between malignant hyperthermia and exertional heat illness? Muldoon S; Deuster P; Brandom B; Bunger R Exerc Sport Sci Rev; 2004 Oct; 32(4):174-9. PubMed ID: 15604937 [TBL] [Abstract][Full Text] [Related]
27. A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient. MacKay EJ; Wilkerson C; Kraeva N; Rosenberg H; Kennedy T J Clin Anesth; 2016 Sep; 33():144-6. PubMed ID: 27555149 [TBL] [Abstract][Full Text] [Related]
28. [New findings and experiences in the field of malignant hyperthermia]. Schulte-Sasse U; Eberlein HJ Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519 [TBL] [Abstract][Full Text] [Related]
30. Malignant hyperthermia: an inherited disorder of skeletal muscle Ca+ regulation. Louis CF; Balog EM; Fruen BR Biosci Rep; 2001 Apr; 21(2):155-68. PubMed ID: 11725864 [TBL] [Abstract][Full Text] [Related]
31. Treatment of Malignant Hyperthermia During Interfacility Transport of a Patient With Methamphetamine Toxicity. Panas A; Walker P Air Med J; 2022; 41(3):320-322. PubMed ID: 35595342 [TBL] [Abstract][Full Text] [Related]
32. Malignant hyperthermia: current perspectives. Felice-Johnson J; Sudds T; Bennett G Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692 [TBL] [Abstract][Full Text] [Related]
34. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394 [TBL] [Abstract][Full Text] [Related]
35. Malignant hyperthermia in Mazovia Province - are we adequately prepared? Cieniewicz A; Trzebicki J Anaesthesiol Intensive Ther; 2022; 54(2):99-102. PubMed ID: 35579281 [TBL] [Abstract][Full Text] [Related]
37. The current status of malignant hyperthermia. Yang L; Tautz T; Zhang S; Fomina A; Liu H J Biomed Res; 2019 May; 34(2):75-85. PubMed ID: 32305961 [TBL] [Abstract][Full Text] [Related]